Precision Neuroscience Corp.
https://precisionneuro.io
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Precision Neuroscience Corp.
Synchron Announces Positive Results From Stentrode BCI Study, Plans For Pivotal Study
After announcing positive results showing that its Stentrode BCI is safe in six patients, brain-computer interface company Synchron is planning a pivotal trial to eventually file for FDA approval.
Company Information
- Industry
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice